Efficient intranasal immunization of newborn mice with recombinant adenovirus expressing rotavirus protein VP4 against oral rotavirus infection

Acta Virologica

Volumn 49, Issue 1, 2005, Pages 17-22

  Liu, X ^a   Yang, T ^b   Sun, Q M ^a   Sun, M S ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

^b KUNMING INSTITUTE OF BOTANY   (China)

Author keywords

Adenoviral vector; Antibodies; Diarrhea; Immunization; Mice; Protection; Rotavirus; VP4 protein

Indexed keywords

ADENOVIRUS VECTOR; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PROTEIN VP4; UNCLASSIFIED DRUG; VIRUS PROTEIN; CAPSID PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; RECOMBINANT VACCINE; ROTAVIRUS VACCINE; VIRUS ANTIBODY; VP4 PROTEIN, ROTAVIRUS;

ADENOVIRUS; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; MOUSE; MOUTH INFECTION; NEWBORN; NONHUMAN; PROPHYLAXIS; PROTEIN EXPRESSION; PROVOCATION TEST; ROTAVIRUS; VIRUS INFECTION; VIRUS RECOMBINANT; ANIMAL; DIARRHEA; GENE VECTOR; GENETICS; IMMUNOLOGY; INTESTINE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MILK; ORAL DRUG ADMINISTRATION; PASSIVE IMMUNIZATION; VACCINATION;

ADENOVIRIDAE; MUS; ROTAVIRUS; SIMIAN ROTAVIRUS;

ADENOVIRIDAE; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; CAPSID PROTEINS; DIARRHEA; GENETIC VECTORS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; INTESTINES; MICE; MILK; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION; VACCINES, SYNTHETIC;

EID: 24944576768     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Andrew ME, Boyle DB, Whitfeld PL, Lockett LJ, Anthony ID, Bellamy AR, Both GW (1990): The immunogenicity of VP7, a rotavirus antigen resident in the endoplasmic reticulum, is enhanced by cell surface expression. J. Virol. 64, 4776-4783.
2. Arias CF, Isa P, Guerrero CA, Mendez E, Zarate S, Lopez T, Espinosa R, Romero P, Lopez S (2002): Molecular biology of rotavirus cell entry. Arch. Med. Res. 33, 356-361.
3. Bass DM, Baylor M, Broome R, Greenberg HB (1992): Molecular basis of age-dependent gastric inactivation of rhesus rotavirus in the mouse. J. Clin. Invest. 89, 1741-1745.
4. Both GW, Lockett LJ, Janardhana V, Edwards SJ, Bellamy AR, Graham FL, Prevec L, Andrew ME (1993): Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc. Virology 193, 940-950.
5. Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB (1996): Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272, 104-107.
6. Chen CC, Baylor M, Bass DM (1993): Murine intestinal mucins inhibit rotavirus infection. Gastroenterology 105, 84-92.
7. Chen SC, Fynan EF, Robinson HL, Lu S, Greenberg HB, Santoro JC, Herrmann JE (1997): Protective immunity induced by rotavirus DNA vaccines. Vaccine 15, 899-902.
8. Choi AH, Basu M, Rae MN, McNeal MM, Ward RL (1998): Particle-bombardment- mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Virology 250, 230-240.
9. Choi AH, Basu M, McNeal MM, Clements JD, Ward RL (1999): Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J. Virol. 73, 7574-7581.
10. Conner ME, Crawford SE, Barone C, Estes MK (1993): Rotavirus vaccine administered parenterally induces protective immunity. J. Virol. 67, 6633-6641.
11. Crawford SE, Estes MK, Ciarlet M, Barone C, O'Neal CM, Cohen J, Conner ME (1999): Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles. J. Virol. 73, 4813-4822.
12. Enouf V, Chwetzoff S, Trugnan G, Cohen J (2003): Interactions of Rotavirus VP4 Spike Protein with the endosomal protein Rab5 and the prenylated rab acceptor PRA1. J. Virol. 77, 7041-7047.
13. Estes MK, Fields BN, Knipe DM (Eds) (1996): Rotavirus and their Replication. Virology III. Raven Press, New York, pp. 1329-1352.
14. Feng N, Lawton JA, Gilbert J, Kuklin, N, Vo P, Prasad BV, Greenberg HB (2002): Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-spccific IgA mAb. J. Clin. Invest. 109, 1203-1213.
15. Giammarioli AM, Mackow ER, Fiore L, Greenberg HB, Ruggeri FM (1996): Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus. Virology 225, 97-110.
16. Gil MT, de Souza CO, Asensi M, Buesa J (2001): Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein. Viral Immunol. 13, 187-200.
17. Herrmann JE, Chen SC, Jones DH, Tinsley-Bown A, Fynan EF, Greenberg HB, Farrar GH (1999): Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles. Virology 259, 148-153.
18. Ijaz MK, Attah-Poku SK, Redmond MJ, Parker MD, Sabara MI, Frenchick P, Babiuk LA (1991): Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus. J. Virol. 65, 3106-3113.
19. Ijaz MK, Nur-E-Kamal MS, Dar FK, Uduman S, Redmond MJ, Attah-Poku SK, Dent D, Babiuk LA (1998): Inhibition of rotavirus infection in vitro and in vivo by a synthetic peptide from VP4. Vaccine 16, 916-920.
20. Kim Y, Nielsen PR, Hodgins D, Chang KO, Saif LJ (2002): Lactogenic antibody responses in cows vaccinated with recombinant bovine rotavirus-like particles (VLPs) of two serotypes or inactivated bovine rotavirus vaccines. Vaccine 20, 1248-1258.
21. Mackow ER, Vo PT, Broome R, Bass D, Greenberg HB (1990): Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. J. Virol. 64, 1698-1703.
22. Mason BB, Graham DY, Estes MK (1980): In vitro transcription and translation of simian rotavirus SA11 gene products. J. Virol. 33, 1111-1121.
23. Nejmeddine M, Trugnan G, Sapin C, Kohli E, Svensson L, Lopez S, Cohen J (2000): Rotavirus spike protein VP4 is present at the plasma membrane and is associated with microtubules in infected cells. J. Virol. 74, 3313-3320.
24. Russell WC (2000): Update on adenovirus and its vectors. J. Gen. Virol. 81, 2573-2604.
25. Sun M, Giambiagi S, Burrone O (1997): VP4 protein of simian rotavirus strain SA11 expressed by a baculovirus recombinant. Zhongguo Yi.Xue.Ke.Xue.YuanXue.Bao 19, 48-53.
26. Sun M, Zan Y, Ma Y, Zhang G, Du Q, Dai C (2001): Expression and glycosylation of rotavirus strain SA11 VP4 protein in a recombinant adenovirus. Chin. Med. Sci. J. 16, 129-134.
27. Van de PP (2003): Transfer of antibody via mother's milk. Vaccine 21, 3374-3376.
28. Ward RL, McNeal MM, Sheridan JF (1992): Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Virology 188, 57-66.
29. Xiang Z, Ertl HC (1999): Induction of mucosal immunity with a replication-defective adenoviral recombinant. Vaccine 17, 2003-2008.